BHT blocks NF-kappaB activation and ethanol-induced brain damage.

Area of Science:

• Neuroscience
• Toxicology
• Pharmacology

Background:

• Binge ethanol consumption causes corticolimbic brain damage, mimicking alcoholic neurodegeneration.
• The precise mechanism behind ethanol-induced neurodegeneration is not fully understood but extends beyond simple excitotoxicity.
• Oxidative stress and inflammation are hypothesized as key contributors to binge ethanol-induced brain damage.

Purpose of the Study:

• To investigate the role of oxidative stress and inflammation in binge ethanol-induced neurodegeneration.
• To evaluate the neuroprotective effects of four antioxidants: butylated hydroxytoluene (BHT), ebselen (Eb), vitamin E (VE), and blueberry (BB) extract.

Main Methods:

• Adult rats received binge ethanol (8-12 g/kg/d) or isocaloric diet for 4 days.
• Antioxidants were co-administered with ethanol to assess neuroprotective effects.
• Brain damage, neurogenesis markers, microglia activation, NF-kappaB-DNA binding, and COX2 expression were analyzed using histochemistry, immunohistochemistry, EMSA, and RT-PCR.

Main Results:

• Binge ethanol induced significant corticolimbic brain damage and reduced neurogenesis.
• Butylated hydroxytoluene (BHT) administration completely reversed ethanol-induced brain damage and prevented the reduction in neurogenesis.
• Other antioxidants (Eb, VE, BB) did not offer protection; however, BHT mitigated ethanol-induced microglia activation, NF-kappaB-DNA binding, and COX2 expression.

Conclusions:

• Binge ethanol-induced brain damage and associated neuroinflammation, evidenced by NF-kappaB activation, are effectively blocked by butylated hydroxytoluene (BHT).
• These findings strongly support a neuroinflammatory mechanism underlying binge ethanol neurotoxicity.
• BHT demonstrates significant neuroprotective potential against the damaging effects of binge ethanol exposure.